These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30198357)

  • 1. Preventing central nervous system metastases in non-small cell lung cancer.
    Krawczyk P; Duchnowska R; Nicoś M; Kowalski D; Wojas-Krawczyk K
    Expert Rev Anticancer Ther; 2018 Nov; 18(11):1077-1083. PubMed ID: 30198357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS metastases in non-small-cell lung cancer: current role of EGFR-TKI therapy and future perspectives.
    Berger LA; Riesenberg H; Bokemeyer C; Atanackovic D
    Lung Cancer; 2013 Jun; 80(3):242-8. PubMed ID: 23453646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapeutic options for treating brain metastases in non-small cell lung cancer.
    Metro G; Chiari R; Ricciuti B; Rebonato A; Lupattelli M; Gori S; Bennati C; Castrioto C; Floridi P; Minotti V; Chiarini P; Crinò L
    Expert Opin Pharmacother; 2015; 16(17):2601-13. PubMed ID: 26439599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic cranial irradiation with combined modality therapy for patients with locally advanced non-small cell lung cancer.
    Cho LC; Dowell JE; Garwood D; Spangler A; Choy H
    Semin Oncol; 2005 Jun; 32(3):293-8. PubMed ID: 15988684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials.
    Shaikh SS; Kumthekar PU; Mohindra NA
    J Neurooncol; 2019 Aug; 144(1):235-237. PubMed ID: 31240523
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research Progress of EGFR-TKI Therapy for Patients with Central Nervous System 
Metastases from Non-small Cell Lung Cancer].
    Jin Y; Xin T
    Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):496-500. PubMed ID: 27561797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer.
    Doherty MK; Korpanty GJ; Tomasini P; Alizadeh M; Jao K; Labbé C; Mascaux CM; Martin P; Kamel-Reid S; Tsao MS; Pintilie M; Liu G; Bradbury PA; Feld R; Leighl NB; Chung C; Shepherd FA
    Radiother Oncol; 2017 May; 123(2):195-202. PubMed ID: 28363487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Brain Metastases in Non-Small-Cell Lung Cancer.
    Ernani V; Stinchcombe TE
    J Oncol Pract; 2019 Nov; 15(11):563-570. PubMed ID: 31715122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitors.
    Wrona A; Dziadziuszko R; Jassem J
    Cancer Treat Rev; 2018 Dec; 71():59-67. PubMed ID: 30366200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: a systematic review and meta-analysis.
    Soon YY; Leong CN; Koh WY; Tham IW
    Radiother Oncol; 2015 Feb; 114(2):167-72. PubMed ID: 25583566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic treatment of brain metastases from lung cancer].
    Barlesi F; Spano JP; Cortot AB; Carpentier AF; Robinet G; Besse B
    Cancer Radiother; 2015 Feb; 19(1):43-7. PubMed ID: 25656857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy.
    Sekine A; Satoh H
    Med Oncol; 2017 Jul; 34(7):121. PubMed ID: 28555261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable brain response with pulse-dose crizotinib and ceritinib in ALK-positive non-small cell lung cancer compared with brain radiotherapy.
    Dudnik E; Siegal T; Zach L; Allen AM; Flex D; Yust-Katz S; Limon D; Hirsch FR; Peled N
    J Clin Neurosci; 2016 Apr; 26():46-9. PubMed ID: 26677785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of non-small cell lung cancer patients harboring activating mutations and CNS progression].
    Rouviere D; Veillon R; Chaltiel L; Simonneau Y; Filleron T; Milia J; Guibert N; Melloni B; Raherison C; Didier A; Mazieres J
    Rev Mal Respir; 2019 May; 36(5):583-590. PubMed ID: 31202602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for EGFR mutant NSCLC with CNS involvement-Can patients BLOOM with the use of next generation EGFR TKIs?
    Tan CS; Cho BC; Soo RA
    Lung Cancer; 2017 Jun; 108():29-37. PubMed ID: 28625644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Therapy of Lung Cancer CNS Metastases Using Molecularly Targeted Agents and Immune Checkpoint Inhibitors.
    O'Kane GM; Leighl NB
    CNS Drugs; 2018 Jun; 32(6):527-542. PubMed ID: 29799091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial.
    Yang JJ; Zhou C; Huang Y; Feng J; Lu S; Song Y; Huang C; Wu G; Zhang L; Cheng Y; Hu C; Chen G; Zhang L; Liu X; Yan HH; Tan FL; Zhong W; Wu YL
    Lancet Respir Med; 2017 Sep; 5(9):707-716. PubMed ID: 28734822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Metastases in NSCLC - are TKIs Changing the Treatment Strategy?
    Dempke WC; Edvardsen K; Lu S; Reinmuth N; Reck M; Inoue A
    Anticancer Res; 2015 Nov; 35(11):5797-806. PubMed ID: 26504000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptomeningeal metastases in non-small-cell lung cancer.
    Cheng H; Perez-Soler R
    Lancet Oncol; 2018 Jan; 19(1):e43-e55. PubMed ID: 29304362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series.
    Metro G; Lunardi G; Bennati C; Chiarini P; Sperduti I; Ricciuti B; Marcomigni L; Costa C; Crinò L; Floridi P; Gori S; Chiari R
    J Neurooncol; 2016 Sep; 129(2):355-61. PubMed ID: 27324494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.